Patent ID: 11865298
Assignee: BRACCO DIAGNOSTICS INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  G | IPC A  G

Claim 29:
30. The method of claim 25, wherein
conveying the radioactive eluate across the beta detector comprises conveying the radioactive eluate through tubing positioned in front of the beta detector and in fluid communication with a waste container until the activity of the radioactive eluate exceeds a threshold and then diverting the flow of the radioactive eluate to the eluate-receiving container;
measuring the beta emissions emitted from the radioactive eluate generated by the radioisotope generator comprises measuring the beta emissions from the radioactive eluate flowing through the eluate line to the eluate-receiving container and determining therefrom an accumulated rubidium radioactive dose supplied to the eluate-receiving container; and
measuring the gamma emissions emitted from the radioactive eluate received by the eluate-receiving container comprises measuring the gamma emissions emitted from the radioactive eluate in the eluate-receiving container within a constancy time window after the end of filling of the eluate-receiving container and determining therefrom an accumulated constancy gamma activity.